Ouroboros Announces Leading $60M Series A Investment in Cytotheryx to Advance Cell Therapy Platform for Liver Disease
PR Newswire —
NEW YORK and SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- Ouroboros Family Founders Fund I, LP announced this week it will lead a $60 million Series A financing in Cytotheryx, Inc., a preclinical cell therapy company developing transformative treatments for liver disease. The announcement...